Cell-specific translational profiling in acute kidney injury

Journal of Clinical Investigation

Volumn 124, Issue 3, 2014, Pages 1242-1254

  Liu, Jing ^a,b,c   Krautzberger, A Michaela ^a,b,c   Sui, Shannan H ^d   Hofmann, Oliver M ^d   Chen, Ying ^a   Baetscher, Manfred ^a   Grgic, Ivica ^e,f   Kumar, Sanjeev ^a,b,c   Humphreys, Benjamin ^e   Hide, Winston A ^d   McMahon, Andrew P ^a,b,c,g,h  

^a HARVARD UNIVERSITY   (United States)

^b Harvard University   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g HARVARD STEM CELL INSTITUTE   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CRE RECOMBINASE; RIBOSOME PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CELL GROWTH; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; DISEASE MODEL; IMMUNOFLUORESCENCE; INTRACELLULAR SPACE; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; LEYDIG CELL; MACROPHAGE; MALE; MESANGIUM CELL; MONOCYTE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; PURIFICATION; REPERFUSION INJURY; TRANSLATING RIBOSOME AFFINITY PURIFICATION; VASCULAR ENDOTHELIUM;

ACUTE KIDNEY INJURY; ANIMALS; GENE ONTOLOGY; GREEN FLUORESCENT PROTEINS; KIDNEY; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY; RIBOSOMAL PROTEINS; TRANSCRIPTOME;

EID: 84896740838     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI72126     Document Type: Article

References (62)

1. Warnock DG. Towards a definition and classification of acute kidney injury. J Am Soc Nephrol. 2005; 16(11):3149-3150.
2. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):844-861.
3. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med. 1987;83(1):65-71.
4. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365-3370.
5. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17(6):1503-1520.
6. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121(11):4210-4221.
7. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2004;30(1):33-37.
8. Humphreys BD, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008; 2(3):284-291.
9. Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012;82(5):516-524.
10. Kim TM, Ramírez V, Barrera-Chimal J, Bobadilla NA, Park PJ, Vaidya VS. Gene expression analysis reveals the cell cycle and kinetochore genes participating in ischemia reperfusion injury and early development in kidney. PLoS One. 2011;6(9):e25679.
11. Yuen PS, Jo SK, Holly MK, Hu X, Star RA. Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol Genomics. 2006;25(3):375-386.
12. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003;63(5):1714-1724.
13. Kieran NE, et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 2003;64(2):480-492.
14. Yoshida T, Tang SS, Hsiao LL, Jensen RV, Ingelfinger JR, Gullans SR. Global analysis of gene expression in renal ischemia-reperfusion in the mouse. Biochem Biophys Res Commun. 2002;291(4):787-794.
15. Yoshida T, et al. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int. 2002;61(5):1646-1654.
16. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463-493.
17. Ko GJ, et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol. 2010; 298(6):F1472-F1483.
18. Paragas N, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med. 2011;17(2):216-222.
19. Heiman M, et al. Development of a BACarray translational profiling approach for the molecular characterization of CNS cell types. Cell. 2008; 135(4):738-748.
20. Doyle JP, et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell. 2008;135(4):749-762.
21. Thomas A, et al. A versatile method for cell-specific profiling of translated mRNAs in Drosophila. PLoS One. 2012;7(7):e40276.
22. Watson FL, Mills EA, Wang X, Guo C, Chen DF, Armstrong NM. Cell type-specific translational profiling in the Xenopus laevis retina. Dev Dyn. 2012;241(12):1960-1972.
23. Tryon RC, Pisat N, Johnson SL, Dougherty JD. Development of translating ribosome affinity purification for zebrafish. Genesis. 2013;51(3):187-192.
24. Kobayashi A, et al. Six2 defines regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008;3(2):169-181.
25. Humphreys BD, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176(1):85-97.
26. Alva JA, et al. VE-Cadherin-Cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn. 2006; 235(3):759-767.
27. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277.
28. Kiss E, et al. Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage. Am J Pathol. 2010;176(5):2150-2162.
29. Balkovetz DF. Tight junction claudins and the kidney in sickness and in health. Biochim Biophys Acta. 2009;1788(4):858-863.
30. Duarte S, Hamada T, Kuriyama N, Busuttil RW, Coito AJ. TIMP-1 deficiency leads to lethal partial hepatic ischemia reperfusion injury. Hepatology. 2012;56(3):1074-1085.
31. Fabian SL, et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol. 2012; 180(4):1441-1453.
32. Astorga J, Carlsson P. Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development. 2007;134(20):3753-3761.
33. Salehi-Tabar R, et al. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc Natl Acad Sci U S A. 2012;109(46):18827-18832.
34. Ayer DE, Eisenman RN. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 1993;7(11):2110- 2119.
35. Larsson LG, Pettersson M, Oberg F, Nilsson K, Lüscher B. Expression of mad, mxi1, max c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad c-myc. Oncogene. 1994;9(4):1247-1252.
36. Khairoun M, et al. Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis. Am J Physiol Renal Physiol. 2013;305(6):F901-F910
37. de Vries DK, et al. Renal ischemia-reperfusion induces release of angiopoietin-2 from human grafts of living deceased donors. Transplantation. 2013; 96(3):282-289.
38. Schioppa T, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003; 198(9):1391-1402.
39. Schutyser E, et al. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells human melanoma cells. Eur Cytokine Netw. 2007;18(2):59-70.
40. Strasser GA, Kaminker JS, Tessier-Lavigne M. Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology branching. Blood. 2010;115(24):5102-5110.
41. Zünd G, et al. Hypoxia enhances induction of endothelial ICAM-1: role for metabolic acidosis proteasomes. Am J Physiol. 1997; 273(5 pt 1):C1571-C1580.
42. Hess DC, Zhao W, Carroll J, McEachin M, Buchanan K. Increased expression of ICAM-1 during reoxygenation in brain endothelial cells. Stroke. 1994;25(7):1463-1467.
43. Kelly KJ, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97(4):1056-1063.
44. Guerrot D, Dussaule JC, Kavvadas P, Boffa JJ, Chadjichristos CE, Chatziantoniou C. Progression of renal fibrosis: the underestimated role of endothelial alterations. Fibrogenesis Tissue Repair. 2012;5(suppl 1):S15.
45. Gardiner NJ, Moffatt S, Fernyhough P, Humphries MJ, Streuli CH, Tomlinson DR. Preconditioning injury-induced neurite outgrowth of adult rat sensory neurons on fibronectin is mediated by mobilisation of axonal alpha5 integrin. Mol Cell Neurosci. 2007;35(2):249-260.
46. Srouji S, et al. Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial longbone defects. Hum Gene Ther. 2012;23(2):167-172.
47. Jin J, et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology glomerular barrier function. Cell. 2012;151(2):384-399.
48. Basile DP, Sutton TA. Activated pericytes and the inhibition of renal vascular stability: obstacles for kidney repair. J Am Soc Nephrol. 2012;23(5):767-769.
49. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens. 2004;13(1):1-7.
50. Leonard EC, Friedrich JL, Basile DP. VEGF-121 preserves renal microvessel structure ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol. 2008;295(6):F1648-F1657.
51. Rovida E, et al. ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. J Immunol. 2008;180(6):4166-4172.
52. Lochhead PA, Gilley R, Cook SJ. ERK5 and its role in tumour development. Biochem Soc Trans. 2012;40(1):251-256.
53. Wang X, Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal. 2006;18(6):753-760.
54. Tsanov KM, Nishi Y, Peterson KA, Liu J, Baetscher M, McMahon AP. An embryonic stem cell-based system for rapid analysis of transcriptional enhancers. Genesis. 2012;50(5):443-450.
55. Aker M, et al. Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum Gene Ther. 2007;18(4):333-343.
56. Kobayashi A, et al. Six2 defines regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008;3(2):169-181.
57. Humphreys BD, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176(1):85-97.
58. Alva JA, et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn. 2006; 235(3):759-767.
59. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277.
60. Weight SC, Furness PN, Bell PR, Nicholson ML. A new model of renal warm ischemia reperfusion injury. Transplant Proc. 1997;29(7):3002-3003.
61. Kennedy SE, Erlich JH. Murine renal ischaemia-reperfusion injury. Nephrology (Carlton). 2008;13(5):390-396.
62. Rumballe B, Georgas K, Little MH. High-throughput paraffin section in situ hybridization and dual immunohistochemistry on mouse tissues. CSH Protoc. 2008;2008:pdbprot5030.